In February 2026, Brad Watts will join biotech leaders on a once-in-a-lifetime climb to summit Mt. Kilimanjaro (19,340 ft / 5,895 m) as part of the Timmerman Traverse.
In 2025 alone, the Traverse raised $1.15M from 1,000+ donors, since 2021
$14M total since 2017 across all causes. This year, the team is raising $1M for the Damon Runyon Cancer Research Foundation, which funds early-career scientists pursuing high-risk, high-reward cancer research.
Why Brad is Doing the Climb.
Diagnosed in 2017 with two forms of aggressive Non-Hodgkin’s Lymphoma at age 29, Brad underwent years of treatment—including chemotherapy, radiation, a stem cell transplant, CAR-T therapy, and immunotherapy—and is now in remission, enjoying life with his wife Shea and their two young sons. As a survivor, patient advocate, and biotech consultant, he has seen firsthand how research transforms lives, and this climb is his way of helping fuel the next
breakthroughs and give patients more time.
Speakers
Sponsors
Platinum Sponsors
Gold Sponsors